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Abstract 
Tuberous sclerosis complex (TSC) is a rare genetic disorder, characterized by 
high incidence of seizures and tubers (benign cellular abnormalities that appear on brain 
imaging). Current literature reports an increased head circumference within the TSC 
population, but the implications, exact rate, or how big the increase is, remains unknown. 
We hypothesized that increased head circumference would correlate with epilepsy 
severity in infants with TSC.  We examined clinical data from 121 infants diagnosed with 
TSC who were enrolled in the multi-site, prospective TSC autism center for excellence 
network (TACERN) study. We calculated each infant’s head circumference z-score from 
each study visit by comparing collected values with those reported by the World Health 
Organization of healthy child head circumference growth. The overall mean head 
circumference z-score across all study visits of all TACERN participants was 0.97 with 
no significant sex differences. The number of seizure types correlated with head 
circumference z-score are as follows: infants with no seizures had a mean z-score of 0.57, 
those with 1 seizure type had a mean z-score of 0.88, and those with 2 or more seizure 
types had a mean z-score of 1.31. Thus, our hypothesis was partially supported. This data 
suggests that a larger head circumference may serve as a biomarker for epilepsy in 





Developmental disabilities are diagnosed at alarmingly high rates. For example, 
autism spectrum disorder (which will be referred to as “autism” here) was present in one 
in every 150 births in the year of 2000; today, it is present in one in every 68 children 
(Center for Disease Control and Prevention (CDC), 2018). TSC is a genetic disorder that 
occurs in one of every 6,000 births and is associated with a high rate of cognitive 
disabilities and autism (Davis et al., 2015). Having a child with a disability can put a lot 
of strain on a family, because that child requires additional care, time, and attention. 
Thus, any research that can improve the neurological outcomes of TSC, or any childhood 
disability may help those affected by the disease. 
Individuals with TSC have an approximate 50% chance of developing autism 
(Curatolo et al., 2015), making TSC one of the most frequent genetic comorbidities, or 
co-occurring diseases, of autism (CDC, 2018). While there is no definitive cause of the 
autism present with (or without) TSC, the autism that occurs with individuals with TSC 
presents similarly to autism alone (Davis et al., 2015). For example, stereotypical 
behaviors seen in autism, such as hand flapping, are seen with autism in TSC. While 
autism is not a major focus of this thesis, if we are able to show that head circumference 
could be a biomarker, or indicator of risk, of severe epilepsy and therefore treat 
individuals sooner, we could preventively treat for autism (i.e.: applied behavioral 
analysis therapy) as well and perhaps lessen the severity of autism-associated symptoms. 
Additionally, by preventively treating for epilepsy alone, we may be preventing damage 
to healthy brain tissue, which could result in autism-associated symptoms. Epilepsy 
occurs in 20% of all cases of autism (Besag, 2017); thus, epilepsy alone may not convey 
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an increased risk of autism, severe epilepsy that is associated with changes in 
neurodevelopment, may increase the risk of autism in patients with TSC. 
Increased head circumference in individuals with TSC 
Interestingly, a common symptom seen in patients with autism alone and TSC 
(with or without autism as a comorbidity) is macrocephaly, or an enlarged head above 2 
standard deviations above the mean, or in the 97th percentile (Lainhart et al.,	2006). The 
rate of macrocephaly in autism is 15.7% as compared to a 3% risk in the typically 
developing population (Viginoli et al., 2015). Macrocephaly occurs at a rate of 14-29.7% 
in TSC and other developmental disorders together, but an exact rate of macrocephaly in 
the TSC population alone was not specified (Sacco et al., 2015). While the literature 
often notes that there is an increased head circumference associated with TSC, the 
literature does not go any further to investigate how macrocephaly relates to the other 
symptoms that occur with TSC.  
The presence and connection between tubers and seizures in individuals with TSC 
In individuals with TSC, many organ systems are affected by the presence of 
hamartomas, collections of abnormal cells. In the brain, these hamartomas are referred to 
as tubers. Tubers are often identified by magnetic resonance imaging (MRI) that may 
have been originally performed to evaluate seizures in an individual with TSC. This is a 
common way that infants are diagnosed with TSC, if there is not a genetic risk of TSC in 
the family. Due to advances in imaging techniques, some fetuses are diagnosed before 
birth because tubers in the brain or hamartomas in the heart are sometimes seen during 
routine prenatal anatomy scans. When this is not the case, as previously mentioned, the 
onset of epilepsy usually leads to a diagnosis. Tubers should not be confused with 
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cancerous tumors, which are large malignant masses of excess tissue that can grow and 
directly cause damage to the body. Tubers are static structures and do not tend to grow 
over the lifetime.  
Tubers can be thought of as a type of benign tumor, that represent areas of a high 
concentration of abnormally developed cells that are produced instead of typical cells. 
Abnormal cells within tubers take the place of healthy cells, rather than the abnormal 
cells adding to the total number of cells in the brain as reviewed by Crino et al. (2010). 
While the exact mechanism of tuber formation is not known, the mechanism of formation 
of subependymal giant cell astrocytomas (SEGAs) (a tumor commonly found in patients 
with TSC) is known, and some researchers have proposed applying the formation 
mechanism of SEGAs to tuber formation as reviewed by Crino et al. (2010). The SEGA 
formation mechanism, when applied to tuber formation, proposes a type of “double hit 
mechanism.” A TSC gene mutation would occur in a neuroepithelial progenitor cell in the 
developing brain, and this mutation would be in conjunction with somatic mutations of 
one of the TSC genes elsewhere, and both lead to dysfunctional proteins produced by the 
TSC genes (reviewed by Crino et al., 2010). The TSC genes are regulators of cell 
development in the mechanistic target of rapamycin (mTOR) pathway (a cell 
development pathway). When this pathway is activated, the mutated protein is not able to 
regulate the activity of mTOR. Thus, cytomegaly occurs in the original progenitor cell 
such that giant cells are created, forming a tuber (reviewed by Crino et al., 2010). This 
information is important, because it suggests that there are cellular changes in the brain in 
those with TSC beyond what we see as tubers; these changes could be contributing to 
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epilepsy, as we know that there is a link between tubers and the type and frequency of 
seizures in those with TSC. 
90% of all TSC patients experience seizures (Vignoli et al., 2015). Tuber burden, 
or the number of tubers in the brain, is correlated to the frequency (i.e.: daily) of seizures. 
Tuber location is known to play a role in the type of seizure seen in an individual with 
epilepsy and TSC. For example, infantile spasms are the most common type of seizures 
seen in infants with a diagnosis of TSC, and it has been demonstrated that a high tuber 
burden in any lobe of the brain conveys a high risk of having infantile spasms (Doherty et 
al., 2005). Infantile spasms are characterized by onset, or start, in infancy and may 
present with a subtle head drop that may go unrecognized as a seizure to a caregiver. In 
the TSC population, 74.5% of individuals who had infantile spasms in infancy later 
developed refractory, or uncontrollable, epilepsy (Chu-Shore et al., 2010). The longer 
infantile spasms go unrecognized, and therefore untreated, the more likely the child is to 
develop refractory epilepsy and developmental disorders (Shields, 2018). Additionally, 
when seizures are left untreated, individuals are at risk for epileptic encephalopathy, or 
damage to healthy tissue, caused by seizures. Since we know this relationship exists, it is 
important to prevent this from happening; if we are able to show that head circumference 
is related to epilepsy severity, we can use head circumference as a biomarker and identify 
which infants may be at risk of the consequences of epilepsy. Eventually, we may even 
be able to treat these high-risk infants preventively, so their epilepsy does not reach the 
refractory status, and thus, decrease the damage to their brains caused by seizures. 
In recent years, there have been vast developments in the research of TSC. 
However, TSC, unlike autism, is not well known to the public, and does not have the 
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immense interest and immediacy of research that autism does. Many researchers have 
reviewed the symptoms associated with TSC and some do note that there is an increased 
rate of macrocephaly, but we have been unable to find any literature investigating the role 
of macrocephaly in the symptomatology, specifically the epilepsy, associated with TSC. 
In fact, the literature has prompted us to examine about the link between head 
circumference and epilepsy in individuals with TSC, but to our knowledge, none has 
been reported to date. Here, we aim to characterize the relationship between head 
circumference and epilepsy severity within infants and toddlers diagnosed with TSC, in 
order to determine if head circumference could be used as a biomarker in the future for 
severe epilepsy in TSC. 
Methods: 
Subject recruitment: 
 Participants in this study were enrolled in the TSC Autism Center of Excellence 
Network (TACERN) at five sites across the United States (Boston Children’s Hospital, 
Cincinnati Children’s Hospital Medical Center, University of Alabama at Birmingham, 
University of California at Los Angeles, and University of Texas at Houston). Infants 
were eligible for the TACERN study if they were diagnosed with TSC before 12 months 
of age. Study visits were at 3, 6, 9, 12, 18, 24, and 36 months of age; however, infants 
could be enrolled into the TACERN study anytime before their first birthday, thus some 
were missing the early study visits. At each study visit, EEG, clinical history, seizure 
diaries, and head circumference measurement were collected. Yearly MRIs on each 
participant were also collected. Full study design, inclusion and exclusion criteria and 
collected information is reported in Davis et al. (2017). Of the 166 TACERN 
	 8 
participants, 121 infants were selected for data analysis in this study. Subjects were 
excluded based on the following criteria: premature birth (before 37 weeks estimated 
gestational age), lack of documented epilepsy history, or lack of head circumference 
measurements. All other participants in the cohort were included. Lastly, as the TACERN 
study is longitudinal in design, we were able to compare the same participants over time. 
Measures: 
World Health Organization’s typical head growth data 
Because the TACERN study did not have healthy controls, we used the World 
Health Organization (WHO) head circumference data for healthy boys and girls from 
birth to age five was used as healthy controls (WHO Multicentre Growth Reference 
Study Group, 2007). The WHO collected data on 8,440 healthy infants who were from 
diverse ethnic backgrounds in order to create typical growth curves (World Health 
Organization, 2007). 
This data was also used to calculate head circumference z-scores for each 
subject’s head circumference measurement using MATLAB R2017a (The MathWorks 
Inc., Natick, MA) using the following z-score formula: 𝑍!,! = 𝐻𝐶!,! − 𝜇!𝜎!  
Where 𝑍!,! is the head circumference z-score for subject i at age d days, 𝐻𝐶!,! is the head 
circumference measurement in cm for subject i at age d days, 𝜇! is the WHO population 
mean head circumference measurement in cm at age d days and 𝜎! is the standard 
deviation of the WHO head circumference measurement at age d days. 
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Before z-scores were calculate, all head circumference measurements were 
manually reviewed for measurement errors. Study sites were queried for any 
measurement that showed a standard deviation change greater than 1, from one 
measurement to the next, as well as any that appeared clearly erroneous (i.e.: a smaller 
head circumference at older age, or a single outlying z-score in a sequence of consecutive 
measurements). If the site could not confirm that the measurement was accurate or 
provide a corrected measurement, that data point was excluded from analysis. 
Head circumference was measured at 3, 6, 9, 12, 18, 24, and 36 months of age, 
although many children did not yet have a 36 month measurement, so the analysis was 
stopped at 24 months. Z-score of head circumference was calculated for each participant 
at each age as well as an average z-score that spanned the first two years of life. In order 
to compare any individual regardless of age and, as boys and older children generally 
have larger heads than girls and younger children, respectively, z-score was used instead 
of head circumference in centimeters.  
In order to directly compare the TACERN and WHO participants, the t-score 
formula, as noted below, was used. We could not use standard t-tests because the WHO 
only publishes average head circumferences for each age, by sex; thus, we compared the 
WHO population to the TACERN sample. Additionally, when comparing the WHO 
participants to the TACERN participants we used centimeters instead of z-score because 
the WHO individuals would always have a z-score of 0; thus, centimeters allows for an 
easier visualization of any potential differences. 
𝑡 = 𝑥 − 𝜇!𝑠/ 𝑛  
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Where 𝑥 is the TACERN sample mean, 𝜇! is the WHO population mean, s is the 
TACERN sample standard deviation, and n is the TACERN sample size. This formula 
generates a t-score, or a critical value, then by using that value, the degrees of freedom 
(n-1), and α =0.05, a p-value can be determined by using a t-distribution table. 
Classifying epilepsy severity: 
 Parents were taught to keep seizure diaries indicating the frequency and type 
(infantile spasms, focal seizures, and other seizure types) of their child’s seizures. To 
assess the severity of epilepsy in each case an adapted version of the early childhood 
epilepsy severity scale (E-Chess) was used, which specifically assesses epilepsy 
associated with TSC and best fit the TACERN data (Humphrey et al., 2008). The full E-
Chess scale includes: seizure frequency (i.e.: daily; not seizure duration), how long 
seizures have been occurring, number of seizure types present, number of antiepileptic 
drugs (AEDs) used, and response to treatment. Many subjects had epilepsy onset prior to 
entering the study or did not have enough seizure diary history recorded to accurately 
determine portions of the E-Chess scale; therefore, an adapted version of the E-Chess 
scale, referred to as a “mini E-Chess” score was created. The mini E-Chess scale was 
based on factors that most subjects had these data recorded. The mini E-Chess score was 
based on number of seizure types and number of AEDs; these categories were scored 
according to Table 1. The data recorded in the seizure diaries was used to generate a mini 
E-Chess score for each participant. The total mini E-Chess severity score is attained by 
adding the score from each parameter. In addition to mini an E-Chess score, number of 
seizure types each infant had was also used as a proxy for epilepsy severity. 
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Table 1: Mini E-Chess scoring of epilepsy severity 
Parameter:    
Number of 
seizure types 
0 = no seizures 1 = 1 type 2 = 2 types 
(continues if 




0 = None 2 = 1 or 2 
AEDs 
3 = More than 2 
AEDs 
 
Then a series of two tailed t-tests were ran to examine differences in head circumference 
z-score based on the types of seizure(s) infants had and the number of seizure types each 
infant had. Number of seizure types TACERN participants was used as a representation 
of epilepsy severity in the t-tests more than the type of seizures, because the latter 
subcategories were very small and thus results may not have been reliable. While the 
number of AEDs was included in the mini E-Chess score, number of AEDs was not used 
as a parameter in the t-tests, because number of AEDs alone does not characterize the 
severity of epilepsy. 
Volumetric analysis of brain size MRIs 
 Brain MRIs were analyzed clinically by radiologists at each participant’s 
respective site and they were analyzed volumetrically by the Warfield lab as outlined in 
Tomas-Fernandez and Warfield (2015). The Warfield lab calculated total brain volume, 
and the distribution of volume between different tissue types (white matter, subcortical 
and cortical grey matter, and cerebrospinal fluid) within the brain. The clinical 
radiologists also reported tuber burden and any other notable brain abnormalities that 
would be grounds for exclusion; 94% of the TACERN sample with MRI data (n=115) 
had cortical tubers.   
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Data analysis plan: 
1. Compare TACERN infants’ head circumferences to WHO’s healthy infants’ head 
circumferences in centimeters. 
2. Determine an average head circumference z-score for each subject that spans the 
first two years of life. Then determine the overall average of the TACERN sample 
using these individual averages.  
3. Examine the relationship between TACERN infants’ head circumference z-score 
and epilepsy severity, based on the number of seizure types, the type each infant 
has, and mini E-Chess score using two tailed t-tests. 
4. Investigate the relationship between age (6, 12, and 24 months) and head 
circumference z-score in TACERN infants using two tailed t-tests. Then analyze 
head circumference based on having epilepsy or not, by age using two tailed t-
tests. 
5. Assess whether or not the onset of seizures increases head circumference at any 
age of seizure onset by comparing the last head circumference measurement 
before seizures started and the first head circumference measurement after 
seizures started with a two tailed t-test.  
6. Analyze the relationship between head circumference and brain volume using 
MRI data and Pearson’s correlational coefficient, r; and determine the distribution 






Average head circumference of all TACERN infants is 1 standard deviation above 
the typically developing population  
 To examine the differences between the TACERN sample and WHO population, 
we used the t-score formula and distribution tables, which revealed there were significant 
differences between the two, at 6, 12, and 24 months of age (Figure 1). We used 
centimeters to better represent the differences, because the WHO population would 
always represent a z-score of zero. 
In order to determine the overall average standardized head circumference z-score 
of all TACERN infants, we first calculated individual averages that spanned the first two 
years of life for each participant. Then we took an average of all participants, which was 
determine to be 0.97 (where the WHO data would have a z-score of 0). This shows that 
head circumferences in TSC are about 1 standard deviation above the normal population, 
as seen in Figure 2A. The average head circumference in centimeters of TACERN 
participants was 43.41 cm. There were no significant sex differences when assessing head 
size by z-score; but as expected based on normal growth standards, male infants had 
overall large head circumferences in centimeters than females. There was a slight 
increase in head circumference z-score with age, which could be due to measurement 
errors or an atypical change in head circumference z-score over time. For very young 
children, measurement errors cause larger deviations due to smaller standard deviations, 
which is important because if errors in head circumference measurements were made, 
they would be more apparent at a young age, rather than an older age, such that there 
would appear to be an increase in z-score overtime. 
	 14 
In order to determine if the increase in head circumference is relative to body size, 
we compared head circumference and height. We did this, because we were interested in 
whether this potential biomarker of overgrowth was localized to the brain or if it occurred 
throughout the body, as represented by height. Head circumference was positively 
correlated to height in this sample; meaning, head size is proportional to the height of the 
infants in TACERN study (Figure 2B). Yet, head circumference of these infants is still 
above average based on age and gender (Figure 2A). This suggests that overgrowth was 
contained to the brain. To further support this we created a histogram (not shown) of 
TACERN infants’ height, and it was a normal distribution with no skewing above or 
below typical heights based on age and sex, suggesting that there were no extreme 
heights in the TACERN sample. 
Epilepsy severity of TACERN infants 
Of our 121 TACERN participants, 94 had seizures. We used the mini E-Chess 
score as described in the methods to determine severity of epilepsy within the group. 
Those who had one seizure type had an average mini E-chess score of 3.29, while those 
with two seizure types had an average mini E-chess score of 4.57. Our participants had an 
average mini E-chess of 3.85, and 54 of the 94 participants with epilepsy were above this 
average. Overall, we had a wide range of epilepsy severity, but also a large representation 
of participants with severe epilepsy. There were more TACERN individuals with 
epilepsy than without; for example, only had 9 of 59 total females did not have epilepsy 
and only 18 of the total 62 males did not have epilepsy. In addition to mini E-chess, we 
decided to use number of seizure type as a variable in our statistical analysis because this 
variable allowed similarly sized groups to make our results reliable, more than using 
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seizure type. Additionally, because mini E-Chess score was varied between all 
participants, using the number of seizure types created comparison groups that were 
unified by a single variable. 
Number of seizure types is proportional to degree of increase in head circumference 
of TACERN infants   
 In order to determine if TACERN individuals with any seizure types had larger 
head circumference z-scores than those who did not have seizures at all, a two tailed t-test 
was used and revealed those with epilepsy were significantly larger than those without 
epilepsy (Figure 3). The average z-score for TACERN participants who did not have 
seizures across all ages was 0.667, therefore, even without epilepsy, head circumference 
is larger in infants with TSC than in healthy infants. TACERN participants with any 
seizures across all ages had an average head circumference z-score of 1.08. However, 
when assessed by seizure type, there was no significant difference in mean head 
circumference z-score for those with only infantile spasms (n=15) versus no seizures 
(n=26), only focal seizures (n=12) versus no seizures (n=26), or only a different seizure 
type (n=1) type versus no seizures (n=26). 67 infants were excluded from this portion of 
the analysis as they had more than one seizure type. This trend suggests that no one type 
of seizure causes the increased head circumference, but the presence of seizures in 
general accounts for the change. Conversely, the lack of significant differences may be 
due to the small sample size of participants having only one seizure type. Since there 
were no significant differences between any one seizure type and head circumference, we 
investigated the role of number of seizure types in in head circumference. As portrayed in 
Figure 4, those with two or more types of seizures had a significantly larger head 
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circumference then those who did not have any seizures, as determined by a two tailed t-
test. This result suggests that having two or more types of seizures, a more severe seizure 
phenotype, is associated with a significantly larger head circumference. 
To determine if the age of seizure onset had an effect on head circumference, we 
examined head circumference z-score by age of seizure onset by using a two tailed t-test, 
and found no correlation. Yet, the start of seizures did have an effect on head 
circumference z-score irrespective of age; head circumference z-score increased from pre 
seizure onset to post seizure onset (Figure 6A). This difference was conserved in those 
who only had one type of seizure, but not in those who had two or more types of seizures 
(Figure 6A). Instead of using age in this analysis, the last head circumference 
measurement when the infant did not have seizures was used as the pre seizure 
measurement, which was compared to the first head circumference measurement once 
seizures started, or the post seizure measurement. We also determined that TACERN 
infants without epilepsy had a significantly different z-score from their first measurement 
to their last, and as noted above, typically developing infants rarely change z-score over 
time (Figure 6B); this suggests that abnormal growth is occurring in the brains of infants 
who have TSC even without having seizures. 
These results could be because those with 2 types of seizures had a bigger head 
circumference from an earlier age, while those with 1 seizure type have more abnormal 
head growth only after they develop seizures. This hypothesis is supported by the fact 
that those with 2 or more types have a significantly larger head circumference than those 
without epilepsy at 6 months of age, but those with only one type of seizures was not 
significantly different at 6 months of age. Overall, this data suggests that having seizures 
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could somehow change the brain and its growth trajectory, beyond the change in growth 
that is accompanied by having just TSC. Lastly, when head circumference was assessed 
by pre and post seizure onset and by individual seizure type, the post onset z-score 
increase was seen in only those who have infantile spasms (data not shown). As noted 
above, z-score should not change over time for head circumference; therefore, we are 
again seeing an abnormal growth rate. 
Data analysis by age reveals 6 months of age may be a critical period in growth 
After analyzing the sample as a whole, irrespective to age, we speculated as to 
whether there was a time point at which these differences appeared. This led us to 
analyze the data by age. Since the TACERN study was longitudinal in design, we were 
able to compare the same participants at 6, 12, and 24 months. We determined that head 
circumference was consistently and significantly above the WHO’s mean at 6, 12, and 24 
months of age when assessing all TACERN participants, with no sex differences in z-
score at any age (Figure 1 and 5).  
In order to determine other factors that may contribute to increased head 
circumference, we analyzed the data based on age and seizure status (whether or not the 
infant had seizures at any time). This analysis revealed that at 6 months of age those who 
had seizures had a significantly larger head circumference z-score than TACERN 
participants who did not have seizures (Figure 5). However, this difference was not 
statistically-significant at 12 or 24 months of age; yet, there were still an apparent 
differences (Figure 5). As seen in Figures 1 and 5, as a population, TACERN participants 
have an increased head circumference consistently through their first two years of life, 
thus the lack of significant differences between those with and without epilepsy at 12 and 
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24 months of age may be due to a small sample size. At 12 months, only 21 infants did 
not have seizures (average z-score= 0.667), while 82 infants did have seizures (average z-
score= 1.22). At 24 months, only 19 infants did not have seizures (average z-score= 
0.871), while 64 did have seizures (average z-score= 1.15). The number of infants was 
slightly different at each age, because some infants were seen too far before or after the 
age of interest. Moreover, at 12 and 24 months (as well as 6 months), by using the t-score 
formula and a two tailed t-distribution, the TACERN population was significantly 
different from the WHO data.  
 Since we determined that number of seizure types influences head size of 
TACERN participants, we next analyzed the data by age and number of seizure types 
using a two tailed t-test to see if there was an age affected the increase in head 
circumference. Again, we observed that the only significant difference was between those 
without epilepsy and those with 2 or more types of seizures, but now we determined this 
difference occurs only at 6 months of age (Figure 7). All of these results together suggest 
that if an infant with TSC has 2 or more types of seizures, there are brain size differences 
such that head circumference is increased early in the child’s life.  
To further characterize the relationship between head circumference and epilepsy 
phenotype, we ran a series of two tailed t-tests, which detected some interesting patterns 
of significant differences in head circumference, by age, number (0, 1, 2 or more) of the 
seizure types and the type of seizure occurring. At 6 months of age, those who had 
infantile spasms and focal seizures had significantly larger head circumferences than 
those who did not have seizures and those who only had infantile spasms (Table 3). At 12 
months of age, those who had infantile spasms and focal seizures had significantly larger 
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head circumferences than those who did not have seizures (Table 3). Additionally at 12 
months, those who had infantile spasms, focal seizures, and at least one other type of 
seizure had significantly larger head circumferences than those who had just infantile 
spasms and those who just had focal seizures (Table 3). At 24 months, those who had 
infantile spasms and one other seizure type had significantly larger head circumferences 
than those who just had infantile spasms (Table 3). From this data, it appears that at any 
age, having more than one seizure type (regardless of how often seizures occur) causes a 
significant increase in head circumference z-score. Moreover, we know that infantile 
spasms are associated with worse neurodevelopmental outcomes (Chu-Shore et al., 2010) 
and from this data; we can see that in every significant difference noted above, the 
children had infantile spasms. Thus having infantile spasms and at least one other seizure 
type may be considered the most severe epilepsy, as represented by the greatest increase 
in head circumference. 
Brain measurements based on MRI data reveal similarities between TACERN 
participants and typically developing population 
 In order to determine if there were obvious physiological differences that could 
account for the increase in head circumference and to determine if head circumference 
was an accurate measurement of brain size, we analyzed the MRIs of TACERN 
participants. Brain volumes calculated from MRI data showed a similar distribution of 
volumes across tissue types within the TACERN sample. Approximately 58% (of total 
brain volume) was cortical grey matter, 3% was subcortical grey matter, 22% was white 
matter, 3% was ventricular systems, and 14% was extra-cerebral spinal fluid (CSF) for all 
subjects in this cohort, with or without epilepsy. This pattern of volumes of tissue types 
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among our subjects is important to note, as the trend suggests that larger head 
circumferences are not because of individual volumetric differences of one tissue type in 
the brain, hydrocephalus, or any other acute abnormality, but rather an overall large 
brain. Moreover, in the volumetric analysis of these MRIs, tubers were included in the 
percentage of volume of tissue type they were found within; for example, if a tuber was 
in the white matter, it added to the total white matter volume. Thus, tubers do not appear 
to change the distribution of tissue volume in the brains of those with TSC. Any 
participant with an acute abnormality, such as hydrocephaly, was excluded from further 
analysis. Additionally, because volumetric measures were positively correlated to head 
circumference, we can conclude that this 1 standard deviation increase in head 
circumference is relative compared to body size (Figure 8).  
To determine if the general trend of distribution of volume of each tissue type was 
similar to the typically developing population, we compared the percentage that each 
tissue type occupied between the two populations. The trend that the TACERN 
participants followed was similar to that of the typically developing population, therefore 
this suggests that large head size is not being caused by a structural difference induced by 
TSC (for example, the presence of cortical tubers). For example, the typical population 
that has a 52% of grey matter (Luders et al., 2002), while TACERN sample has 58% grey 
matter. We cannot say that there is no significant difference here, because Luders et al. 
(2002) did not report individual data points so we could not run two tailed t-tests between 
TACERN participants and the healthy controls. Therefore, while head circumference and 
consequently total brain volume was increased in the TACERN sample, it is not because 
any one tissue type is significantly increased. 
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Intracranial cavity (ICC), or total brain volume including everything within the 
skull, was positively correlated to head circumference based on all TACERN 
participants’ brain MRIs (Figure 8A). This is important, as it suggests that head 
circumference was an accurate measure of brain volume, as shown previously. White 
matter and subcortical and cortical grey matter volumes were also positively correlated 
with head circumference (Figure 8B, 9C, and 9D respectively). Positive correlations 
between the tissue volumes and head circumference is as expected, because the amount 
of tissue should be proportional to head size. As expected, males had overall larger brain 
volumes than females, as predicted by larger body size (World Health Organization, 
2018). Lastly, larger head circumference was not due to increased CSF, as all individuals 
in this sample had normal CSF volumes as compared to the typically developing 
population (data not shown).  
Review and results of data analysis plan: 
1. TACERN infants’ head circumferences were about 1 standard deviation above the 
WHO’s healthy infants’ head circumferences. 
2. The average head circumference z-score for all subjects, spanning each 
participants' first two years of life (individual average of each head circumference 
measurement) was 0.97. 
3. TACERN infants’ head circumference z-score was proportional to epilepsy 
severity, based on the number of seizure types each infant has. With no seizures, 
TACERN infants had an average z-score of 0.57, with one seizure type the 
average was 0.881, and with two or more types of seizures, the average was1.31 
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4. At 6 months of age, TACERN infants without epilepsy had an average z-score of 
0.482, while those who did have seizures was 1.12. At 12 months of age, 
TACERN infants without epilepsy had an average z-score of 0.667, while those 
who did have seizures was 1.22. At 24 months of age, TACERN infants without 
epilepsy had an average z-score of 0.871, while those who did have seizures was 
1.15. 
5. The start of seizures increases head circumference at any age of seizure onset 
when TACERN infants had only one type of seizures, but not when TACERN 
infants had two or more types of seizures. 
6. Using two tailed t-tests, it was determined that infantile spasms, more than focal 
seizures or other seizure types, increased head circumference the most. 
7. Head circumference and brain volume were positively correlated, as determined 
by MRI data. 
Discussion 
Most TACERN participants have an increased head circumference, but not 
macrocephaly 
When originally designing this project, we hypothesized the majority of the TACERN 
infants would meet clinical criteria for macrocephaly, as the literature intermittently 
reported that macrocephaly was a symptom of TSC and because of the presence of tubers 
and seizures in individuals with TSC; however this was not the case. As mentioned in the 
introduction, macrocephaly is defined as a head circumference that is two or more 
standard deviations above the mean, as reported by the WHO, (Lainhart et al., 2006), and 
the TACERN infants on average had an increase in head circumference z-score of one 
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standard deviation. Yet, we did have a rate of 19.8% infants who met criteria for 
macrocephaly, which is still elevated from the 3% rate in the typical population and a 
15.7% rate in those with autism (Vignoli et al., 2015). This supported our hypothesis that 
the rate of macrocephaly is elevated in the TSC population. Most of our subjects had an 
increased head circumference but not increased enough to meet criteria for macrocephaly. 
Thus, we believe that an increased head circumference of approximately 1 standard 
deviation above the WHO mean, is a more accurate descriptor of head circumference 
differences in those with TSC. Additionally, it has been previously demonstrated that 
head circumference is an accurate predictor of brain volume, especially in young 
children; thus, differences in head circumference represents differences in brain volume 
(Bartholomeusz et al., 2002). Furthermore, since head circumference was positively 
correlated to brain volume in the TACERN sample, our analysis of head circumference is 
likely an accurate measurement of brain size. Thus, overgrowth of head circumference 
represents over growth in the brain. 
Epilepsy severity is proportional to the increase in head circumference in TACERN 
participants 
Through our analysis of epilepsy severity, we observed a number of trends that 
related epilepsy severity to head circumference. First, since we demonstrated that overall, 
TSC carries a risk of an increased head circumference, because we found that as a whole, 
the average head circumference z-score of the TACERN population was 0.97 (Figure 
2A). The average head circumference z-score for TACERN participants without epilepsy 
was 0.57, while the average head circumference z-score for TACERN participants with 
epilepsy was 1.08; this difference was statistically significant (Figure 3). This supported 
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our hypothesis that those TACERN infants with epilepsy had a larger head circumference 
than those TACERN infants without epilepsy. We also determined that those with TSC 
without epilepsy increased z-score of head circumference over the course of their first 
two years, which suggests that even without epilepsy, TSC is associated with abnormal 
head growth as head circumference percentile is typically stable over the lifetime (Figure 
6B).  
The abnormal change in head circumference z-score in those without epilepsy 
could potentially be because the brains of those with TSC without epilepsy, still have 
abnormal cellular growth that leads to larger cells, cellular migration, and subtle 
microscopic differences and therefore they have overall larger brains. An example of 
these microscopic differences is that, some cells do not migrate properly, thus some 
portions of the brain are subtlety structurally different from a healthy brain. For those 
who do not have tubers, there are likely still unhealthy cells within the brain. This is 
because those without tubers still have the mutation of one of the TSC genes that causes 
TSC and also cause the unhealthy cells, just likely at lower concentrations such that no 
visible tuber is formed. To confirm these hypotheses, in the future it would be helpful if 
more post-mortem studies were conducted to determine if these discrete cellular 
abnormalities are present in the brains of those with TSC without epilepsy and or without 
tubers, and to determine how exactly they change the brain. Crino et al. (2010) reviewed 
studies that have noted some microscopic differences, as mentioned above, in those TSC 
that were not visible on MRI, but were identified post mortem. This is important, because 
if those without tubers, still have an increased head circumference, potentially caused by 
these abnormal cells, then head circumference could be used as a diagnostic tool of TSC, 
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for individuals who do not have tubers which is a common way of diagnosing TSC. 
While each change is so minor, many such changes could constitute an increased head 
circumference. 
Second, we determined that those with the most severe epilepsy, as characterized 
by having two or more types of seizures, had the largest head circumferences in the 
sample. This too supported our hypothesis that epilepsy severity would be correlated to 
head circumference. We determined that those with two or more types of seizures had an 
average head circumference z-score of 1.31, while those who had only one type of 
seizures had an average head circumference of 0.88 (Figure 4). At 6 months of age, those 
with two or more types of seizures had a significantly larger head circumference than 
those without epilepsy, but this difference was not statistically significant at 12 or 24 
months (Figure 7). Because there was no statistical difference in those with and without 
epilepsy at 12 to 24 months, this suggests that 6 months may be a critical point in 
development for those with severe epilepsy, such that head growth rate begins to slow 
down, as head circumference was consistently high at 6,12, and 24 months for those with 
epilepsy. Additionally, there were no statistically significant differences in head 
circumference at any age between those with 1 type of seizure and those without epilepsy 
(Figure 7).  
Third, those with one type of seizure had a significant head circumference 
increase after their seizures began, but this was not seen in those with two or more types 
of seizures (Figure 6A). For infants with 1 seizure type, it appears that their heads grow at 
a similar rate to those without epilepsy until seizures start. For example, one participant 
with 1 seizure type had a consistent head circumference z-score of 0.66 before seizures 
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began, then after seizures began, head circumference z-score increased to 1.42. This 
participant represented the trend nicely, as there was a slight increase in head 
circumference, similar to those without epilepsy, before the seizures began. After seizures 
began, we observed a large increase in head circumference z-score, which may represent 
an anatomical change in the brain that could be causing the seizures. These trends are 
outlined below in Table 2.   
Table 2: Head Circumference z-score by Seizure Status 
Age (months) Average head circumference z-
score with epilepsy 
Average head circumference z-
score without epilepsy 
6  1.12 0.482 
12 1.22 0.667 
24  1.15 0.871 
 
In every result of statistical analysis that was significantly different based on the 
type of seizures, infantile spasms were occurred in those who had larger head 
circumferences. This is important because we know that infantile spasms in particular are 
detrimental to infants’ development, leading to refractory epilepsy and epileptic 
encephalopathy (Chu-Shore et al., 2010). This suggests that infantile spasms affect brain 
growth in a way that focal spasms or other seizure types do not, as there was only a 
significant post seizure onset z-score increase in those with infantile spasms alone, but 
not any other one seizure type. Another possibility is that infantile spasms typically have 
an earlier onset than focal seizures, so the change in head circumference may be greater 
from a younger age. If we can reduce the rate of refractory epilepsy, we also could be 
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reducing the amount of resulting cognitive impairments, and improving the outcomes of 
infants with TSC. 
We conclude that increased head circumference could be used as a biomarker in 
TSC in one of three ways. First, having a head circumference that is slightly above 
average from a young age, could suggest that the infant may have TSC, if it has not 
already been diagnosed. A TSC diagnosis can then be confirmed with a genetic test. 
Second, if the increase in head circumference is slight, between half a standard deviation 
and 1 standard deviation above the mean, there is also a risk that this child may have mild 
epilepsy (1 seizure type). Third, for those who have an increased head circumference of 
about 1 standard deviation or above the mean, there is a risk of severe epilepsy (2 or more 
types of seizures).  This biomarker could be further tested by performing regular 
electroencephalograms on all infants diagnosed with TSC in order to diagnose and track 
seizures, in addition to the yearly MRIs most individuals with TSC have to track tubers. 
If our conclusions were supported in the future, after additional research is conducted, 
only those who carry a risk of seizures would need to continue those diagnostic tests. 
Additionally, if the risk of severe epilepsy is supported then, perhaps these children can 
be proactively treated with an anti-epileptic in order to reduce the chance of refractory 
epilepsy as a preventative measure. As mentioned above, those with TSC have an 
approximate 50% chance of developing autism, and by having early onset severe 
epilepsy, individuals risk of developing increases, because the seizures damage healthy 
brain tissue. Thus, if we are able to control epilepsy, such that it does not damage healthy 
tissue, we could reduce the rate of autism in the TSC population. We could further this 
effort, by not only preventively treating epilepsy, but perhaps we could preventively treat 
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autism (i.e.: with applied behavioral analysis therapy) to further decrease the rate of 
autism in TSC. 
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Figure 1. Average head circumference of TACERN participants and WHO reveals 
differences between typically developing children and children with TSC. By using the t-
score formula and a two tailed t-distribution, significant differences at 6,12, and 24 
months were detected. Centimeters were used in this figure, because the WHO population 
would always represent a z-score of 0, thus centimeters makes the difference easier to 






























































Figure 2. Above average head circumference z-score of all TACERN participants is 
proportional to their height. A. The average head circumference z-score of all TACERN 
participants was 0.97, with no significant sex differences between TACERN participants 
(p=0.298, two tailed t-test, when α=0.05). B. A positive correlation between head 
circumference and height (Pearson’s r= 0.867; p=2.96e-183, two tailed t-test, when 
α=0.05), suggests that the larger head circumference was relative to body size. Average 
head circumference of TACERN participants was still above the expected average based 

















































Figure 3. TACERN infants with epilepsy have a significantly larger head circumference 
z-scores than TACERN infants without epilepsy. Those who had any seizure type (red) 
had a significantly larger z-score than those who did not have seizures (blue) (p=0.0487, 
tailed t-test, when α =0.05). The average head circumference z-score for those with 
epilepsy was 1.08, while the average for those without epilepsy was 0.571. There was no 
significant difference in head circumference z- score between those TACERN 
participants without epilepsy compared to TACERN infants with any one type of seizure 














































Figure 4. Infants with two seizure types have a significantly larger head circumference z-
score. As previously mentioned, individuals with epilepsy had larger head circumference 
z-scores, however when analyzed by the number of seizure types, only those with two or 
more seizure types had significantly larger head circumference z-scores than those with 
epilepsy. Those with no seizures had an average head circumference z-score of 0.571, 
one seizure type had a z-score of 0.881 and with two types of seizures, and the average z-
score was 1.31. The average z-score of all participants with at least one type of seizure 

















































Figure 5. Analysis of head circumference z-score at 6, 12, and 24 months of all 
TACERN participants, by epilepsy status, reveals an increased head circumference that is 
consistent throughout infancy and larger for those with epilepsy. The closest 
measurement to each of the time points was used instead of average z-score across the 
first two years of life, as in Figure 2A; most infants were not seen at exactly 6, 12, or 24 
months, therefore the closest visit to each age was used. At 6 months of age, head 
circumference z-score significantly differed between those who did and did not have 
seizures The average head circumference z-score for those who did have seizures at 6 
months was 1.12, the average for those who did not was 0.482. At 12 months of age, head 
circumference z-score was not significantly differed between those who did and did not 
have seizures (p=0.059, two tailed t-test, when α =0.05). The average head 
circumference z-score for those who did have seizures at 12 months was 1.22, the 
average for those who did not was 0.667. At 24 months of age, head circumference z-
score was not significantly differed between those who did and did not have seizures 
(p=0.342, two tailed t-test, when α =0.05). The average head circumference z-score for 
those who did have seizures at 24 months was 1.15, the average for those who did not 
was 0.871. Although there was no statistically significant difference between those with 
and without epilepsy at 12 and 24 months, there are consistent increases in the mean z-
























































Figure 6. Difference in pre and post seizure onset head circumference z-score for 
TACERN infants with one seizure type but not with two seizure types; and increase in z-
score for TACERN infants without epilepsy overtime. A. For TACERN participants with 
one seizure type, their head circumference z-score was significantly different from pre to 
post seizure onset; this significant difference was conserved when tested with any 
participant who had any number of seizure types. However, for TACERN participants 
with two or more seizure types, there was no significant difference in pre and post seizure 
onset head circumference z-score (p=0.229, two tailed t-test, when α =0.05). TACERN 
participants who do not have epilepsy had a significantly larger head circumference z-
score from their first measurement to their last measurement. This suggests that even 
without epilepsy, those with TSC have larger heads than the typically developing 
population, and infants with TSC change percentile of head circumference, unlike the 



































































Figure 7. Difference in head circumference z-score between infants with two or more 
seizure types and infants without epilepsy is localized to 6 months of age. As seen in 
Figure 5, there were differences in head circumference between infants with and without 
epilepsy at 6 months of age, however that difference was driven by infants with 2 or more 
seizure types as shown here, this is the only significant difference. When analyzing the 
data in this manner, each subcategory had a fairly small sample size, thus other 
relationships may exist that were not present in our sample. * Indicates p<0.05  
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Table 3: Two tailed t-tests of head circumference z-score by seizure status 
✚Represents a significant difference 
IS= infantile spasms, FS= focal spasms, SZ= seizures, All= IS, FS, and OS, OS=other 
seizure type; N/A represents too small of a sample size to run a two tailed t-test; Values 
represent p-values when α =0.05 using a two tailed t-test 
 
  
t-test 6 Months 12 Months 24 Months 
IS and FS vs no SZ 0.0078✚ 0.023✚ 0.492 
IS and FS vs IS 0.0076✚ 0.174 0.806 
IS vs all 0.720 0.024✚ 0.803 
IS and OS vs no SZ N/A 0.278 0.053 
IS and OS vs IS N/A N/A 0.035✚ 
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Figure 8. Brain volumes of all participants were correlated to average head 
circumference, suggesting head circumference is an accurate measure of brain size. This 
data includes all TACERN participants- with and without epilepsy. A. Total brain volume 
(ICC, intracranial cavity) was positively correlated with head circumference (r=0.919, 
p=8.74e-131, two tailed t-test, when α =0.05). This suggests that larger head 
circumference was not due to measurement errors or hair volume. Additionally, head 
circumference is an effective measure of brain size. B. White matter (WM) volume was 
positively correlated and significantly related to head circumference (r=0.884 and 
p=6.91e-107, two tailed t-test, when α =0.05). C. Subcortical grey matter (GM) volume 
was positively correlated to head circumference (r=-0.841, p=7.14e-87, two tailed t-test, 
when α =0.05). D. Cortical grey matter volume was also positively correlated to head 
circumference (r=0.847, p=2.47e-89, two tailed t-test, when α =0.05). The linear fit of 
these graphs were similar but slightly better than a cubic fit, and a cubic relationship 
between volume (mm3) and head circumference (cm1) as previously demonstrated in the 
literature.  
 
